Johnson & Johnson has three buyers in its latest consumer health product divestment. Rights to its 1% ketoconazole anti-dandruff shampoo, branded Nizatrol A-D in the US, are going to a separate firm for each of the US-Latin America, Asia-Pacific and Europe-Middle East-Africa regions.
J&J’s Belgian pharma division, Janssen Pharmaceutica NV, is selling US and Latin American rights to the formulation to Kramer...